#news #biotech Lilly, AstraZeneca halt phase 3 Alzheimer’s trials for futility, further denting BACE prospects

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Lilly, AstraZeneca halt phase 3 Alzheimer’s trials for futility, further denting BACE prospects .Eli Lilly and AstraZeneca have pulled the plug on two phase 3 trials of BACE inhibitor lanabecestat in Alzheimer’s disease. The partners stopped the studies after an independent interim analysis deemed they were destined to fail.

from FierceBiotech: Biotech https://ift.tt/2t1s76z